KMT2A

From WikiMD's Wellness Encyclopedia

Revision as of 17:31, 18 February 2025 by Prab (talk | contribs) (CSV import)

Overview of the KMT2A gene and its significance in human biology


KMT2A Gene

The KMT2A gene, also known as MLL (Mixed-Lineage Leukemia), is a crucial gene located on chromosome 11q23.3. It encodes a protein that functions as a histone methyltransferase, which is essential for the regulation of gene expression through chromatin modification. The KMT2A protein plays a significant role in the regulation of gene expression, cell cycle, and developmental processes.

File:Histone methylation.png
Histone methylation is a key process regulated by KMT2A.

Function

The KMT2A protein is part of a large multiprotein complex that specifically methylates histone H3 at lysine 4 (H3K4). This methylation is a marker of active chromatin and is associated with transcriptional activation. The KMT2A complex is involved in the regulation of homeobox (HOX) genes, which are critical for embryonic development and hematopoiesis.

Clinical Significance

Mutations and translocations involving the KMT2A gene are implicated in various forms of leukemia, particularly acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). These genetic alterations often result in the formation of fusion proteins that disrupt normal gene regulation, leading to uncontrolled cell proliferation.

Leukemia

Translocations involving KMT2A are found in approximately 5-10% of acute leukemias. The most common translocation is t(4;11)(q21;q23), which results in the fusion of KMT2A with the AF4 gene. This fusion protein acts as an aberrant transcription factor, driving the expression of genes that promote leukemogenesis.

Leukemia cells often exhibit chromosomal translocations involving KMT2A.

Research and Therapeutic Approaches

Research into the KMT2A gene and its associated pathways is ongoing, with the aim of developing targeted therapies for leukemias involving KMT2A translocations. Strategies include the use of small molecule inhibitors that target the KMT2A fusion proteins or their downstream signaling pathways.

Related Pages

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD weight loss doctors team
W8MD weight loss doctors team

W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:

NYC weight loss doctor appointmentsNYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Linkedin_Shiny_Icon Facebook_Shiny_Icon YouTube_icon_(2011-2013) Google plus


Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.